| UniProt ID | GPDM_HUMAN | |
|---|---|---|
| UniProt AC | P43304 | |
| Protein Name | Glycerol-3-phosphate dehydrogenase, mitochondrial | |
| Gene Name | GPD2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 727 | |
| Subcellular Localization | Mitochondrion. | |
| Protein Description | ||
| Protein Sequence | MAFQKAVKGTILVGGGALATVLGLSQFAHYRRKQMNLAYVKAADCISEPVNREPPSREAQLLTLQNTSEFDILVIGGGATGSGCALDAVTRGLKTALVERDDFSSGTSSRSTKLIHGGVRYLQKAIMKLDIEQYRMVKEALHERANLLEIAPHLSAPLPIMLPVYKWWQLPYYWVGIKLYDLVAGSNCLKSSYVLSKSRALEHFPMLQKDKLVGAIVYYDGQHNDARMNLAIALTAARYGAATANYMEVVSLLKKTDPQTGKVRVSGARCKDVLTGQEFDVRAKCVINATGPFTDSVRKMDDKDAAAICQPSAGVHIVMPGYYSPESMGLLDPATSDGRVIFFLPWQKMTIAGTTDTPTDVTHHPIPSEEDINFILNEVRNYLSCDVEVRRGDVLAAWSGIRPLVTDPKSADTQSISRNHVVDISESGLITIAGGKWTTYRSMAEDTINAAVKTHNLKAGPSRTVGLFLQGGKDWSPTLYIRLVQDYGLESEVAQHLAATYGDKAFEVAKMASVTGKRWPIVGVRLVSEFPYIEAEVKYGIKEYACTAVDMISRRTRLAFLNVQAAEEALPRIVELMGRELNWDDYKKQEQLETARKFLYYEMGYKSRSEQLTDRSEISLLPSDIDRYKKRFHKFDADQKGFITIVDVQRVLESINVQMDENTLHEILNEVDLNKNGQVELNEFLQLMSAIQKGRVSGSRLAILMKTAEENLDRRVPIPVDRSCGGL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 33 | Acetylation | QFAHYRRKQMNLAYV HHHHHHHHHCCHHHH | 44.92 | 30589025 | |
| 41 | Acetylation | QMNLAYVKAADCISE HCCHHHHHHHHHCCC | 25.77 | 30589031 | |
| 47 | Phosphorylation | VKAADCISEPVNREP HHHHHHCCCCCCCCC | 42.02 | - | |
| 67 | O-linked_Glycosylation | QLLTLQNTSEFDILV HEEEECCCCCCCEEE | 19.37 | 23301498 | |
| 80 | O-linked_Glycosylation | LVIGGGATGSGCALD EEECCCCCCCCHHHH | 34.84 | 23301498 | |
| 83 (in isoform 2) | Ubiquitination | - | 11.32 | - | |
| 94 | Ubiquitination | DAVTRGLKTALVERD HHHHHCHHEEEEECC | 34.28 | - | |
| 104 | Phosphorylation | LVERDDFSSGTSSRS EEECCCCCCCCCCCC | 34.55 | - | |
| 105 | Phosphorylation | VERDDFSSGTSSRST EECCCCCCCCCCCCC | 46.19 | - | |
| 113 | Ubiquitination | GTSSRSTKLIHGGVR CCCCCCCEEECCHHH | 46.84 | - | |
| 121 | Phosphorylation | LIHGGVRYLQKAIMK EECCHHHHHHHHHHC | 15.86 | - | |
| 128 | Ubiquitination | YLQKAIMKLDIEQYR HHHHHHHCCCHHHHH | 36.57 | - | |
| 128 (in isoform 2) | Ubiquitination | - | 36.57 | - | |
| 138 | Ubiquitination | IEQYRMVKEALHERA HHHHHHHHHHHHHHH | 28.11 | - | |
| 190 | Methylation | VAGSNCLKSSYVLSK HHCCCCCCHHHHCCC | 39.29 | - | |
| 191 | Phosphorylation | AGSNCLKSSYVLSKS HCCCCCCHHHHCCCC | 17.60 | 20860994 | |
| 196 | Phosphorylation | LKSSYVLSKSRALEH CCHHHHCCCCHHHHH | 20.67 | 20860994 | |
| 197 | Ubiquitination | KSSYVLSKSRALEHF CHHHHCCCCHHHHHC | 39.54 | - | |
| 197 | 2-Hydroxyisobutyrylation | KSSYVLSKSRALEHF CHHHHCCCCHHHHHC | 39.54 | - | |
| 209 | 2-Hydroxyisobutyrylation | EHFPMLQKDKLVGAI HHCCCCCCCCEEEEE | 53.52 | - | |
| 211 | 2-Hydroxyisobutyrylation | FPMLQKDKLVGAIVY CCCCCCCCEEEEEEE | 52.70 | - | |
| 218 | Phosphorylation | KLVGAIVYYDGQHND CEEEEEEEECCCCCC | 6.96 | - | |
| 246 | Phosphorylation | YGAATANYMEVVSLL HCHHHCCHHHHHHHH | 7.68 | - | |
| 251 | Phosphorylation | ANYMEVVSLLKKTDP CCHHHHHHHHHCCCC | 32.91 | 24719451 | |
| 271 | Ubiquitination | RVSGARCKDVLTGQE EEECCEECCCCCCCC | 45.37 | - | |
| 275 | Phosphorylation | ARCKDVLTGQEFDVR CEECCCCCCCCEEEE | 36.35 | - | |
| 284 | Ubiquitination | QEFDVRAKCVINATG CCEEEEEEEEEECCC | 20.62 | - | |
| 290 | Phosphorylation | AKCVINATGPFTDSV EEEEEECCCCCCHHH | 40.68 | 20068231 | |
| 294 | Phosphorylation | INATGPFTDSVRKMD EECCCCCCHHHCCCC | 30.42 | 20068231 | |
| 296 | Phosphorylation | ATGPFTDSVRKMDDK CCCCCCHHHCCCCHH | 22.29 | 20068231 | |
| 347 (in isoform 2) | Ubiquitination | - | 24.57 | - | |
| 355 | Phosphorylation | KMTIAGTTDTPTDVT EEEEECCCCCCCCCC | 36.64 | - | |
| 357 | Phosphorylation | TIAGTTDTPTDVTHH EEECCCCCCCCCCCC | 26.46 | - | |
| 359 | Phosphorylation | AGTTDTPTDVTHHPI ECCCCCCCCCCCCCC | 45.23 | - | |
| 362 | Phosphorylation | TDTPTDVTHHPIPSE CCCCCCCCCCCCCCH | 19.78 | - | |
| 378 (in isoform 2) | Ubiquitination | - | 39.13 | 21906983 | |
| 382 | Phosphorylation | ILNEVRNYLSCDVEV HHHHHHHHHCCCEEE | 6.88 | 20068231 | |
| 384 (in isoform 2) | Ubiquitination | - | 9.64 | - | |
| 384 | Phosphorylation | NEVRNYLSCDVEVRR HHHHHHHCCCEEEEC | 9.64 | 20068231 | |
| 409 | Ubiquitination | RPLVTDPKSADTQSI CCCCCCCCCCCCCCC | 62.17 | - | |
| 413 | Phosphorylation | TDPKSADTQSISRNH CCCCCCCCCCCCCCC | 24.75 | 28102081 | |
| 415 | Phosphorylation | PKSADTQSISRNHVV CCCCCCCCCCCCCEE | 25.32 | 28102081 | |
| 417 | Phosphorylation | SADTQSISRNHVVDI CCCCCCCCCCCEEEE | 32.07 | 28102081 | |
| 453 | 2-Hydroxyisobutyrylation | DTINAAVKTHNLKAG HHHHHHHHHCCCCCC | 39.06 | - | |
| 453 | Ubiquitination | DTINAAVKTHNLKAG HHHHHHHHHCCCCCC | 39.06 | - | |
| 458 | 2-Hydroxyisobutyrylation | AVKTHNLKAGPSRTV HHHHCCCCCCCCCEE | 57.52 | - | |
| 458 | Ubiquitination | AVKTHNLKAGPSRTV HHHHCCCCCCCCCEE | 57.52 | - | |
| 476 | Phosphorylation | LQGGKDWSPTLYIRL EECCCCCCCEEHEEH | 20.38 | - | |
| 480 | Phosphorylation | KDWSPTLYIRLVQDY CCCCCEEHEEHHHHH | 6.10 | 22817900 | |
| 487 | Phosphorylation | YIRLVQDYGLESEVA HEEHHHHHCCHHHHH | 13.40 | 28152594 | |
| 504 (in isoform 1) | Ubiquitination | - | 51.08 | 21906983 | |
| 504 | Ubiquitination | LAATYGDKAFEVAKM HHHHHCHHHHHHHHH | 51.08 | 2190698 | |
| 510 | Ubiquitination | DKAFEVAKMASVTGK HHHHHHHHHHHCCCC | 39.93 | - | |
| 510 | 2-Hydroxyisobutyrylation | DKAFEVAKMASVTGK HHHHHHHHHHHCCCC | 39.93 | - | |
| 513 | Phosphorylation | FEVAKMASVTGKRWP HHHHHHHHCCCCCCC | 19.40 | 20068231 | |
| 515 | Phosphorylation | VAKMASVTGKRWPIV HHHHHHCCCCCCCEE | 34.19 | 20068231 | |
| 517 | 2-Hydroxyisobutyrylation | KMASVTGKRWPIVGV HHHHCCCCCCCEEEE | 41.76 | - | |
| 532 | Phosphorylation | RLVSEFPYIEAEVKY EEEEECCEEEEEHHH | 19.40 | - | |
| 544 | Phosphorylation | VKYGIKEYACTAVDM HHHCCHHHHHHHHHH | 11.28 | - | |
| 547 | Phosphorylation | GIKEYACTAVDMISR CCHHHHHHHHHHHHH | 22.88 | - | |
| 553 | Phosphorylation | CTAVDMISRRTRLAF HHHHHHHHHHHHHHH | 14.74 | - | |
| 586 | Phosphorylation | RELNWDDYKKQEQLE CCCCHHHHHHHHHHH | 20.01 | - | |
| 587 | 2-Hydroxyisobutyrylation | ELNWDDYKKQEQLET CCCHHHHHHHHHHHH | 55.78 | - | |
| 600 | Phosphorylation | ETARKFLYYEMGYKS HHHHHHHHHHHCCCC | 10.66 | 29759185 | |
| 601 | Phosphorylation | TARKFLYYEMGYKSR HHHHHHHHHHCCCCH | 11.11 | 29759185 | |
| 605 | Phosphorylation | FLYYEMGYKSRSEQL HHHHHHCCCCHHHHC | 12.41 | 29759185 | |
| 607 | Phosphorylation | YYEMGYKSRSEQLTD HHHHCCCCHHHHCCC | 32.33 | 27251275 | |
| 609 | Phosphorylation | EMGYKSRSEQLTDRS HHCCCCHHHHCCCHH | 36.46 | 27251275 | |
| 619 | Phosphorylation | LTDRSEISLLPSDID CCCHHHHHCCCHHHH | 21.57 | 23186163 | |
| 623 | Phosphorylation | SEISLLPSDIDRYKK HHHHCCCHHHHHHHH | 47.36 | - | |
| 634 | Acetylation | RYKKRFHKFDADQKG HHHHHHHCCCCCCCC | 42.08 | 19608861 | |
| 634 | Malonylation | RYKKRFHKFDADQKG HHHHHHHCCCCCCCC | 42.08 | 26320211 | |
| 634 | Ubiquitination | RYKKRFHKFDADQKG HHHHHHHCCCCCCCC | 42.08 | 19608861 | |
| 640 | 2-Hydroxyisobutyrylation | HKFDADQKGFITIVD HCCCCCCCCCEEEEE | 57.23 | - | |
| 723 | Phosphorylation | VPIPVDRSCGGL--- CCCCCCCCCCCC--- | 16.79 | 25159151 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of GPDM_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of GPDM_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of GPDM_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| COX2_HUMAN | COX2 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-634, AND MASS SPECTROMETRY. | |